These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study. Prasher VP; Adams C; Holder R; Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681 [No Abstract] [Full Text] [Related]
11. Neuroleptic malignant-like syndrome due to donepezil and maprotiline. Ohkoshi N; Satoh D; Nishi M; Shoji S Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986 [No Abstract] [Full Text] [Related]
12. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome. Hemingway-Eltomey JM; Lerner AJ Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967 [No Abstract] [Full Text] [Related]
14. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia. Alwahhabi FK J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444 [TBL] [Abstract][Full Text] [Related]
15. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern. Wolff ML Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625 [TBL] [Abstract][Full Text] [Related]
16. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874 [No Abstract] [Full Text] [Related]